These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 18029066)
1. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium. Costa WA; Cunha RS; Bolzan VL; Silva Ade C; Caporale GM; Chaves LB; Oselka GW; Junqueira DA; Panacho MR; Dias RA; Takaoka NY Vaccine; 2007 Nov; 25(48):8140-5. PubMed ID: 18029066 [TBL] [Abstract][Full Text] [Related]
2. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV). Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033 [TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis. Wang LY; Sun MP; Zhang XC; Suo LD; Xu RH; Zou YJ; Zuo LB; Qi H Vaccine; 2011 Mar; 29(15):2679-81. PubMed ID: 21296694 [TBL] [Abstract][Full Text] [Related]
5. Studies on clinical trials and immune effect of a new purified rabies vaccine prepared from Vero cells. Dong G; Zheng H; Liu Z Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):19-23. PubMed ID: 11503018 [TBL] [Abstract][Full Text] [Related]
6. An immunogenicity study of a newly introduced purified Vero cell rabies vaccine (Abhayrab) manufactured in India. Sampath G; Reddy SV; Rao ML; Rao YU; Palaniappan C Vaccine; 2005 Jan; 23(7):897-900. PubMed ID: 15603890 [TBL] [Abstract][Full Text] [Related]
7. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of purified Vero-cell rabies vaccine in severely rabies-exposed patients in China. Wang XJ; Lang J; Tao XR; Shu JD; Le Mener V; Wood SC; Huang JT; Zhao SL Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):287-94. PubMed ID: 11127328 [TBL] [Abstract][Full Text] [Related]
9. [Studies on the manufacture and immunogenicity of purified rabies vaccines on humans Vero cell]. Yu W; Liu Z; Qian H; Lu H; Wang H; Li F; Dou Z Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):17-9. PubMed ID: 11860837 [TBL] [Abstract][Full Text] [Related]
10. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis. Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149 [TBL] [Abstract][Full Text] [Related]
11. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen. Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value]. Hacibektaşoğlu A; Inal A; Eyigün C; Barut A; Türkay FA Mikrobiyol Bul; 1992 Jan; 26(1):26-36. PubMed ID: 1574019 [TBL] [Abstract][Full Text] [Related]
13. A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China. Li R; Huang L; Li J; Mo Z; He B; Wang Y; Wu X; Minutello M; Guinet-Morlot F; Pichon S Vaccine; 2013 Dec; 31(50):5940-7. PubMed ID: 24148575 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies. Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India. Matha IS; Salunke SR Clin Infect Dis; 2005 Feb; 40(4):611-3. PubMed ID: 15712086 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety study of Indirab: a Vero cell based chromatographically purified human rabies vaccine. Sampath G; Madhusudana SN; Sudarshan MK; Ashwathnarayana DH; Mahendra BJ; Ullas TP; Mohan K; Madhusudhan SK; Ravish HS Vaccine; 2010 May; 28(24):4086-90. PubMed ID: 20403351 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the safety, immunogenicity, and pharmacokinetic profile of a new, highly purified, heat-treated equine rabies immunoglobulin, administered either alone or in association with a purified, Vero-cell rabies vaccine. Lang J; Attanath P; Quiambao B; Singhasivanon V; Chanthavanich P; Montalban C; Lutsch C; Pepin-Covatta S; Le Mener V; Miranda M; Sabchareon A Acta Trop; 1998 Jul; 70(3):317-33. PubMed ID: 9777717 [TBL] [Abstract][Full Text] [Related]
19. Post-exposure prophylaxis with purified vero cell rabies vaccine during pregnancy--safety and immunogenicity. Sudarshan MK; Madhusudana SN; Mahendra BJ J Commun Dis; 1999 Dec; 31(4):229-36. PubMed ID: 10937299 [TBL] [Abstract][Full Text] [Related]
20. BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans. Lalosević D; Lalosević V; Lazarević-Ivanc Lj; Knezević I Dev Biol (Basel); 2008; 131():421-9. PubMed ID: 18634504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]